Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Type II restriction endonuclease MamI

Type II restriction endonuclease MamI

US Patent 5153122 · Granted Oct 6, 1992

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the prediction of a personalized ESA-dose in the treatment of anemia2020
Anti-alpha-synuclein antibodies and methods of use2020
Antibodies against human CSF-1R and uses thereof2019
Anti-alpha-synuclein antibodies and methods of use2019
Antibodies against human CSF-1R and uses thereof2019
Antibodies against human CSF-1R and uses thereof2018
Antibodies against human CSF-1R and uses thereof2018
Antibodies against human CSF-1R and uses thereof2018
Antibodies against human CSF-1R and uses thereof2018
Antibodies against human CSF-1R and uses thereof2018
Anti-alpha-synuclein antibodies and methods of use2018
Antibodies against human CSF-1R and uses thereof2018